Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study
Crossref DOI link: https://doi.org/10.1007/s00277-014-2103-3
Published Online: 2014-05-14
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Witzens-Harig, Mathias
FoĆ”, Robin
Di Rocco, Alice
van Hazel, Guy
Chamone, Dalton F. A.
Rowe, Jacob M.
Arcaini, Luca
Poddubnaya, Irina
Ho, Anthony D.
Ivanova, Valentina
Vranovsky, Andrej
Thurley, Dan
Oertel, Stephan
Text and Data Mining valid from 2014-05-14